title: Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma.
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Medical College of Cornell University, New York, NY;
authors.forename: Nikoletta
authors.initials: N
authors.lastname: Lendvai
authors.affiliation: Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Yee
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
authors.forename: Ioanna
authors.initials: I
authors.lastname: Tsakos
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
authors.forename: Aeri
authors.initials: A
authors.lastname: Alexander
authors.affiliation: Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY; and.
authors.forename: Sean M
authors.initials: SM
authors.lastname: Devlin
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Medical College of Cornell University, New York, NY;
authors.forename: Hani
authors.initials: H
authors.lastname: Hassoun
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Medical College of Cornell University, New York, NY;
authors.forename: Neha
authors.initials: N
authors.lastname: Korde
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Medical College of Cornell University, New York, NY;
authors.forename: Alexander M
authors.initials: AM
authors.lastname: Lesokhin
authors.affiliation: Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Heather
authors.initials: H
authors.lastname: Landau
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Medical College of Cornell University, New York, NY;
authors.forename: Sham
authors.initials: S
authors.lastname: Mailankody
authors.affiliation: Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Guenther
authors.initials: G
authors.lastname: Koehne
authors.affiliation: Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: David J
authors.initials: DJ
authors.lastname: Chung
authors.affiliation: Myeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY; Department of Medicine, Weill Medical College of Cornell University, New York, NY;
authors.forename: Ola
authors.initials: O
authors.lastname: Landgren
authors.affiliation: Division of Hematology and Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;
authors.forename: Noopur S
authors.initials: NS
authors.lastname: Raje
authors.affiliation: Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
authors.forename: Sergio
authors.initials: S
authors.lastname: Giralt
mesh_terms: D000368:Aged; D000813:Anilides / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use*; D011725:Pyridines / Q000627:therapeutic use*; D020794:Receptor Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D000813:Anilides; D047428:Protein Kinase Inhibitors; D011725:Pyridines; C558660:cabozantinib; D020794:Receptor Protein-Tyrosine Kinases